Log In
Print
BCIQ
Print
Print this Print this
 

NOSO-95

  Manage Alerts
Collapse Summary General Information
Company Nosopharm S.A.S.
DescriptionAntibacterial molecule
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationBacterial infection
Indication DetailsTreat multidrug resistant hospital-acquired infections
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today